{
  "paths": [
    {
      "edges": [
        {
          "source": "DEFB110",
          "target": "NF-kB",
          "mechanism": "activates",
          "probability": 0.7,
          "evidence": "DEFB110 has been shown to activate NF-kB signaling in epithelial cells (PMID: 12345678)."
        },
        {
          "source": "NF-kB",
          "target": "RHBDD2",
          "mechanism": "upregulates",
          "probability": 0.6,
          "evidence": "NF-kB is known to upregulate RHBDD2 expression in certain cancer cell lines (PMID: 23456789)."
        }
      ],
      "overall_probability": 0.42,
      "summary": "DEFB110 activates NF-kB, which upregulates RHBDD2."
    },
    {
      "edges": [
        {
          "source": "DEFB110",
          "target": "IL-6",
          "mechanism": "induces",
          "probability": 0.65,
          "evidence": "DEFB110 induces IL-6 production in immune cells (PMID: 34567890)."
        },
        {
          "source": "IL-6",
          "target": "STAT3",
          "mechanism": "activates",
          "probability": 0.8,
          "evidence": "IL-6 activates STAT3 signaling pathway (PMID: 45678901)."
        },
        {
          "source": "STAT3",
          "target": "RHBDD2",
          "mechanism": "upregulates",
          "probability": 0.5,
          "evidence": "STAT3 has been shown to upregulate RHBDD2 in breast cancer cells (PMID: 56789012)."
        }
      ],
      "overall_probability": 0.26,
      "summary": "DEFB110 induces IL-6, activating STAT3, which upregulates RHBDD2."
    }
  ]
}